1. Home
  2. MAMA vs ZURA Comparison

MAMA vs ZURA Comparison

Compare MAMA & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mama's Creations Inc.

MAMA

Mama's Creations Inc.

HOLD

Current Price

$16.49

Market Cap

649.2M

ML Signal

HOLD

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$6.47

Market Cap

435.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAMA
ZURA
Founded
2010
2022
Country
United States
United States
Employees
N/A
30
Industry
Specialty Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
649.2M
435.0M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
MAMA
ZURA
Price
$16.49
$6.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$16.80
$11.78
AVG Volume (30 Days)
450.2K
461.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$95,420,129.00
N/A
Revenue This Year
$41.59
N/A
Revenue Next Year
$33.43
N/A
P/E Ratio
$210.75
N/A
Revenue Growth
95.54
N/A
52 Week Low
$6.05
$0.99
52 Week High
$17.85
$7.25

Technical Indicators

Market Signals
Indicator
MAMA
ZURA
Relative Strength Index (RSI) 57.57 50.67
Support Level $15.36 $5.62
Resistance Level $17.85 $6.99
Average True Range (ATR) 0.75 0.50
MACD -0.07 -0.09
Stochastic Oscillator 53.01 30.91

Price Performance

Historical Comparison
MAMA
ZURA

About MAMA Mama's Creations Inc.

Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: